G

Grape King Bio Ltd
TWSE:1707

Watchlist Manager
Grape King Bio Ltd
TWSE:1707
Watchlist
Price: 126.5 TWD
Market Cap: 18.7B TWD

Operating Margin
Grape King Bio Ltd

20.8%
Current
23%
Average
5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.8%
=
Operating Profit
2.2B
/
Revenue
10.4B

Operating Margin Across Competitors

No Stocks Found

Grape King Bio Ltd
Glance View

Market Cap
18.7B TWD
Industry
Consumer products

Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. The company is headquartered in Taoyuan, Taoyuan. The firm operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The firm operates in Taiwan, mainland China and other markets.

Intrinsic Value
202.69 TWD
Undervaluation 38%
Intrinsic Value
Price
G
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.8%
=
Operating Profit
2.2B
/
Revenue
10.4B
What is the Operating Margin of Grape King Bio Ltd?

Based on Grape King Bio Ltd's most recent financial statements, the company has Operating Margin of 20.8%.

Back to Top